Molecular techniques such as polymerase chain reaction (PCR) and next-generation sequencing (NGS) can complement histology by providing additional genetic and molecular information. These techniques can identify biomarkers and genetic mutations that guide targeted therapies. However, integrating molecular data with histological findings requires specialized knowledge and infrastructure, posing challenges in routine clinical practice.
